首页> 美国卫生研究院文献>Internal Medicine >Retroperitoneal Bulky Histiocytic Sarcoma Successfully Treated with Induction Chemotherapy Followed by Curative Surgery
【2h】

Retroperitoneal Bulky Histiocytic Sarcoma Successfully Treated with Induction Chemotherapy Followed by Curative Surgery

机译:诱导化疗后根治性手术成功治疗腹膜后大块组织细胞肉瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm. We report a patient with HS treated with induction chemotherapy followed by curative surgery. A 50-year-old man was referred to our hospital because of a retroperitoneal tumor. A computed tomography scan revealed a bulky retroperitoneal mass, infiltrating the surrounding organ. An excisional biopsy confirmed the diagnosis of HS. The tumor shrunk after multidrug chemotherapy. However, positron emission tomography showed uptake of fludeoxyglucose in the residual tumor. He underwent right nephrectomy to remove the tumor. Pathological examination showed complete response. Surgery combined with induction chemotherapy may be an effective way to manage HS.
机译:组织细胞肉瘤(HS)是一种罕见的造血肿瘤。我们报告了一名HS患者接受诱导化疗后再进行根治性手术。一名50岁的男子因腹膜后肿瘤被转诊到我们医院。计算机断层扫描显示腹膜后部肿块浸润周围器官。切除活检证实了HS的诊断。多药化疗后肿瘤缩小。然而,正电子发射断层扫描显示残留肿瘤中氟氧葡萄糖的摄取。他接受了右肾切除术以切除肿瘤。病理检查显示完全反应。手术结合诱导化疗可能是治疗HS的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号